MS Australia has partnered with
La Trobe University to launch a new
website for people with MS, their
family members and carers,
makingsenseofmsresearch.org.au.
The website uses summaries of
scientifically rigorous Cochrane
Reviews to create a place that
people affected with MS can go to
seek unbiased, first-class
information on medications and
treatments.
“This kind of information is
normally only available to doctors,
so to have it accessible to people
living with the disease every day is
a great step forward,” said MS
Australia Acting Chief Executive
Officer Trevor Farrell.
“People with chronic illnesses like
MS deserve to be able to use web
technology like this to empower
them to be in charge of their
future,” he added.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Nov 12
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.